[Retracted] DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database

Table 3

Univariate analysis and multivariate analysis of the correlation of DNM1 expression with OS among CC patients.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)		Hazard ratio (95% CI)
Age (>65 vs. ≤65)	477	1.610 (1.052-2.463)	0.028	2.366 (1.011-5.536)	0.047
Gender (male vs. female)	477	1.101 (0.746-1.625)	0.627
T stage (T3 & T4 vs. T1 & T2)	476	3.072 (1.423-6.631)	0.004	0.730 (0.134-3.986)	0.716
N stage (N1 & N2 vs. N0)	477	2.592 (1.743-3.855)	<0.001	0.153 (0.014-1.609)	0.118
M stage (M1 vs. M0)	414	4.193 (2.683-6.554)	<0.001	3.022 (1.158-7.887)	0.024
Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II)	466	2.947 (1.942-4.471)	<0.001	17.160 (1.348-218.491)	0.029
Perineural invasion (yes vs. no)	181	1.940 (0.982-3.832)	0.056	0.979 (0.388-2.470)	0.964
Lymphatic invasion (yes vs. no)	433	2.450 (1.614-3.720)	<0.001	1.318 (0.512-3.392)	0.567
DNM1 (high vs. low)	477	1.725 (1.163-2.558)	0.007	2.370 (0.859-6.536)	0.096